Delivery Order SPE2DB20D1100-SPE2DB24FA3M3

Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $18K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,908.63 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4557297388 Lidocaine 5% Patch 30s. This delivery order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lidocaine 5% Patch 30s. The $1,130.91 contract has an ultimate completion date of April 8, 2024 and does not include any set-aside designation. This delivery order contract is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that DLA previously awarded to AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $2,608.26 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lidocaine 5% patches. The order was placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC is the primary vehicle for AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of lidocaine 5% patches. The order, valued at $10,864.32, has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lidocaine 5% Patches. The $1,954.88 award has a completion date of May 17, 2022. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds with DLA. The IDC, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lidocaine 5% patches. The contract has a potential value of $3,137.10 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,199.73 to Amerisourcebergen Drug Corp, a leading pharmaceutical sourcing and distribution company, for the supply of 4564119721 - Lidocaine 5% Patch 30s. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563970513 - Lidocaine 5% Patch 30s. The contract has a ceiling value of $1,399.79 and a performance period through March 15, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,858.27 firm fixed price delivery order for 4557313676 - Lidocaine 5% Patch 30s. This order was placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563981413 - Lidocaine 5% Patches in packages of 30. The contract, valued at $24,220.56, has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a prime contractor for the DLA, providing a range...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA3M3
    Delivery Order

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563731648 - Lidocaine 5% Patch 30s. The contract has a completion date of February 22, 2024 and a potential value of $17,643.58. This delivery order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.

Generated 5/22/24, 10:01 AM